Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Inhibits Lipogenesis AOD-9604 suppresses the formation of new fat cells by downregulating enzymes involved in fat synthesis
Do not use drugs that are labelled "For Research Use Only Not for Human Consumption"
Add R13.12 or another phase code second when the study documents the phase
Real-world weight loss expectations Conservative estimate (most people): 8-10% body weight loss at 2.4mg weekly Example: 220 lbs 198-202 lbs (18-22 lbs lost) 68 weeks to maximum Realistic, achievable Average responder: 10-12% body weight loss Example: 220 lbs 194-198 lbs (22-26 lbs lost) Typical trial results Most common outcome Excellent responder: 12-15% body weight loss Example: 220 lbs 187-194 lbs (26-33 lbs lost) 20-30% of users Good adherence + lifestyle With combination (CagriSema): 15-25% body weight loss Example: 220 lbs 165-187 lbs (33-55 lbs lost) Superior results Requires both peptides Factors affecting results: Starting weight (higher = more absolute pounds) Diet adherence (protein intake critical) Exercise (resistance training preserves muscle) Sleep quality (affects metabolism) Stress levels (cortisol impacts weight) Medication adherence Access personalized protocols at SeekPeptides - our AI advisor helps optimize your cagrilintide weight loss journey based on your specific situation
BPC-157 is also prohibited by the World Anti-Doping Agency (WADA), making it banned for use in most competitive sports
US$ 23.63
US$ 29.92
US$ 23.43
US$ 24.53
